Dwafil 10

Dwafil 10

Pharmacodynamic properties:-
 Tadalafil is a potent, selective, reversible inhibitor of cyclic guanosine 
  monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). 
 When sexual stimulation causes the local release of nitric oxide, 
 inhibition of PDE5 by Tadalafil produces increased levels of cGMP in 
 the corpus cavernosum. This results in smooth muscle relaxation and 
 inflow of blood into the penile tissues, thereby producing an erection.  
 Tadalafil has no effect in the absence of sexual stimulation. 
 Tadalafil administered to healthy subjects produced no significant 
 difference compared to placebo in supine systolic and diastolic blood 
 pressure, or in standing systolic and diastolic blood pressure, and no 
 significant change in heart rate. 
 There were no clinically relevant effects on sperm concentration, sperm  
 count, motility or morphology after daily doses of  10 mg and 20 mg 
 for 6 months. 
Pharmacokinetic properties:- 
- Tadalafil is readily absorbed after oral administration and the mean 
  maximum observed plasma concentration (Cmax) is achieved at a 
  median time of 2 hours after dosing. 
- The rate and extent of absorption of tadalafil are  not influenced by 
  food, thus Tadalafil may be taken with or without food. The time of 
  dosing (morning versus evening) had no clinically relevant effects on 
  the rate and extent of absorption. 
- The mean volume of distribution is approximately 63 liters, indicating 
  that tadalafil is distributed into tissues. At therapeutic concentrations, 
  94% of Tadalafil in plasma is bound to proteins. Protein binding is not 
  affected by impaired renal function. 
- Less than 0.0005% of the administered dose appeared in the semen of 
   healthy subjects. 
- Tadalafil is predominantly metabolized by the cytochrome P450 
   (CYP3A4) isoform.
- The mean oral clearance for tadalafil is 2.5 L/hr and the mean half-life 
   is 17.5 hours in healthy subjects. 
- Tadalafil is excreted predominantly as inactive metabolites, mainly in 
   the faeces (approximately 61% of the dose) and to a lesser extent in 
   the urine (approximately 36% of the dose). 

-  Each film-coated tablet of  Dwafil® 20 contains:
   Tadalafil     20 mg
-  Each film-coated tablet of  Dwafil® 10 contains:
   Tadalafil     10 mg

- Dwafil® is contraindicated in anyone taking organic nitrates as it may 
  potentiate their hypotensive effects. 
- Hypersensitivity to any component of the tablet. 

 Dwafil® is principally metabolized by CYP3A4; a selective inhibitor of 
 CYP3A4, Ketoconazole increased tadalafil AUC by 107% and a 
 CYP3A4 inducer, Rifampicin, reduced tadalafil AUC by 88% relative to 
 the AUC values for Tadalafil alone. 
 Simultaneous administration of an antacid (magnesium 
 hydroxide/aluminum hydroxide) and Dwafil® reduce the apparent rate 
 of absorption of Tadalafil without altering exposure (AUC) to Tadalafil. 

 Dwafil® is not indicated for use in women. 

Effects on ability to drive and use machines:-
 Patients should be aware of how they react to Dwafil®, before driving or 
 operating machinery. 

- The most common side effects are headache and indigestion. 
- less commonly reported side effects are back pain, muscle aches, 
  flushing and nasal congestion. 
- These side effects usually go away after few hours.

Over dose:- 
 Single doses of up to 500 mg have been given to healthy subjects, and 
 multiple daily doses up to 100 mg have been given to patients. Adverse 
 effects were similar to those seen at lower doses. In cases of overdose, 
 standard supportive measures should be adopted as required

  Dwafil® should be used with caution in patients who have conditions 
  such as:
- Patients with severe cardiovascular disease.
- Patients with severe renal insufficiency.
- Patients with severe hepatic insufficiency.
- Patients who have conditions that might predispose them to priapism 
  (such as sickle cell anaemia, multiple myeloma or leukaemia).
- Patients with anatomical deformation of the penis.

 Blister of 2 tablets, pack of  two blisters. 
 

 Store in the original package , at a temperature not exceeding  30o C.